ifosfamide has been researched along with Anaplastic Large-Cell Lymphoma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therapy for group non-B patients (lymphoblastic lymphoma and pleomorphic T-cell lymphoma [PTCL]) consisted of a Berlin-Frankfurt-Münster (BFM) acute lymphoblastic leukemia protocol, including cranial irradiation for advanced stage." | 2.68 | Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. ( Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamoto, K | 1 |
| Suzuki, T | 1 |
| Kasami, T | 1 |
| Kiryu, M | 1 |
| Sone, H | 1 |
| Miyoshi, H | 1 |
| Ohshima, K | 1 |
| Takizawa, J | 1 |
| Sun, XF | 1 |
| Zhen, ZJ | 1 |
| Xiang, XJ | 1 |
| Ling, JY | 1 |
| Peng, RJ | 1 |
| Xia, Y | 1 |
| Zheng, L | 1 |
| Luo, WB | 1 |
| Lin, H | 1 |
| Guan, ZZ | 1 |
| Dawn, G | 1 |
| Morrison, A | 1 |
| Morton, R | 1 |
| Bilsland, D | 1 |
| Jackson, R | 1 |
| Ng, A | 1 |
| Hobson, R | 1 |
| Williams, D | 1 |
| Morland, B | 1 |
| Mandal, S | 1 |
| Varma, K | 1 |
| Jain, S | 1 |
| Reiter, A | 1 |
| Schrappe, M | 1 |
| Parwaresch, R | 1 |
| Henze, G | 1 |
| Müller-Weihrich, S | 1 |
| Sauter, S | 1 |
| Sykora, KW | 1 |
| Ludwig, WD | 1 |
| Gadner, H | 1 |
| Riehm, H | 1 |
| Engelhard, M | 1 |
| Brittinger, G | 1 |
| Huhn, D | 1 |
| Gerhartz, HH | 1 |
| Meusers, P | 1 |
| Siegert, W | 1 |
| Thiel, E | 1 |
| Wilmanns, W | 1 |
| Aydemir, U | 1 |
| Bierwolf, S | 1 |
| Griesser, H | 1 |
| Tiemann, M | 1 |
| Lennert, K | 1 |
1 review available for ifosfamide and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Anaplastic large cell lymphoma of bone--is it a bad tumor?
Topics: Activin Receptors, Type II; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, | 2007 |
3 trials available for ifosfamide and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2009 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 1995 |
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 1997 |
3 other studies available for ifosfamide and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.
Topics: Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bren | 2019 |
Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fem | 2003 |
Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; | 2008 |